Clinical trial
A Single-blind Randomized Comparative Study of the Safety and Pharmacokinetics of Complarate and Actemra® in the Form of a Solution for Subcutaneous Administration in Parallel Groups of Healthy Volunteers
NCT06488521 is registered in ClinicalTrials.gov with AO GENERIUM as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Single-blind Randomized Comparative Study of the Safety and Pharmacokinetics of Complarate and Actemra® in the Form of a Solution for Subcutaneous Administration in Parallel Groups of Healthy Volunteers
- Lead sponsor
- AO GENERIUM
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- June 20, 2024
- Completion date
- July 28, 2025
- Enrollment
- 256 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
healthy volunteers